These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7151844)

  • 1. Pharmacokinetic properties of carprofen in humans.
    Crevoisier C
    Eur J Rheumatol Inflamm; 1982; 5(4):492-502. PubMed ID: 7151844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal clearance of carprofen in the isolated perfused rat kidney.
    Bekersky I; Colburn WA
    Drug Metab Dispos; 1981; 9(1):25-9. PubMed ID: 6111427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of urine alkalization and activated charcoal on the pharmacokinetics of orally administered carprofen in dogs.
    Raekallio MR; Honkavaara JM; Säkkinen MS; Peltoniemi SM
    Am J Vet Res; 2007 Apr; 68(4):423-7. PubMed ID: 17397299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of benoxaprofen in subjects with normal and impaired renal function, prediction of multiple-dose kinetics.
    Brogard JM; Comte F; Madon M; Spach MO
    Eur J Rheumatol Inflamm; 1982; 5(2):113-23. PubMed ID: 7084275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of liver dysfunction on the pharmacokinetics of carprofen.
    Holazo AA; Chen SS; McMahon FG; Ryan JR; Konikoff JJ; Brazzell RK
    J Clin Pharmacol; 1985 Mar; 25(2):109-14. PubMed ID: 3886707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific assay and stereospecific disposition of racemic carprofen in rats.
    Kemmerer JM; Rubio FA; McClain RM; Koechlin BA
    J Pharm Sci; 1979 Oct; 68(10):1274-80. PubMed ID: 512860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of carprofen in plasma and synovial fluid.
    Ray JE; Wade DN; Graham GG; Day RO
    J Clin Pharmacol; 1979 Oct; 19(10):635-43. PubMed ID: 512061
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral versus intravenous vinorelbine: clinical safety profile.
    Gebbia V; Puozzo C
    Expert Opin Drug Saf; 2005 Sep; 4(5):915-28. PubMed ID: 16111453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of benoxaprofen in elderly subjects.
    Hamdy RC; Murnane B; Perera N; Woodcock K; Koch IM
    Eur J Rheumatol Inflamm; 1982; 5(2):69-75. PubMed ID: 7084284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics and metabolism of 14C-carprofen in man.
    Ray JE; Wade DN
    Biopharm Drug Dispos; 1982; 3(1):29-38. PubMed ID: 7082777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
    Tompson DJ; Vearer D
    Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic studies of benoxaprofen in geriatric patients.
    Kamal A; Koch IM
    Eur J Rheumatol Inflamm; 1982; 5(2):76-81. PubMed ID: 7084285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First human exposure to exogenous single-dose oral estetrol in early postmenopausal women.
    Visser M; Holinka CF; Coelingh Bennink HJ
    Climacteric; 2008; 11 Suppl 1():31-40. PubMed ID: 18464021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantioselective glucuronidation and subsequent biliary excretion of carprofen in horses.
    Soraci A; Benoit E; Jaussaud P; Lees P; Delatour P
    Am J Vet Res; 1995 Mar; 56(3):358-61. PubMed ID: 7771704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of piroxicam in man.
    Hobbs DC
    Eur J Rheumatol Inflamm; 1983; 6(1):46-55. PubMed ID: 6861813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.